209 related articles for article (PubMed ID: 36389695)
1. Identification of a novel sepsis prognosis model and analysis of possible drug application prospects: Based on scRNA-seq and RNA-seq data.
He H; Huang T; Guo S; Yu F; Shen H; Shao H; Chen K; Zhang L; Wu Y; Tang X; Yuan X; Liu J; Zhou Y
Front Immunol; 2022; 13():888891. PubMed ID: 36389695
[TBL] [Abstract][Full Text] [Related]
2. Identification of sepsis-associated mitochondrial genes through RNA and single-cell sequencing approaches.
Li S; Li X; Jiang S; Wang C; Hu Y
BMC Med Genomics; 2024 May; 17(1):120. PubMed ID: 38702721
[TBL] [Abstract][Full Text] [Related]
3. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
Front Oncol; 2021; 11():711020. PubMed ID: 34621670
[TBL] [Abstract][Full Text] [Related]
4. Construction of monocyte-related prognosis model based on comprehensive analysis of bulk RNA-seq and single-cell RNA-seq in high-grade serous ovarian cancer.
Xu Y; Tan S; Huang W; Wang YX
Medicine (Baltimore); 2023 Dec; 102(50):e36548. PubMed ID: 38115318
[TBL] [Abstract][Full Text] [Related]
5. Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer.
Wen XY; Wang RY; Yu B; Yang Y; Yang J; Zhang HC
Sci Rep; 2023 Sep; 13(1):15597. PubMed ID: 37730847
[TBL] [Abstract][Full Text] [Related]
6. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
7. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
8. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.
Zhou Y; Guo Y; Wang Y
IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485
[TBL] [Abstract][Full Text] [Related]
10. Integrated proteome sequencing, bulk RNA sequencing and single-cell RNA sequencing to identify potential biomarkers in different grades of intervertebral disc degeneration.
Yang X; Lu Y; Zhou H; Jiang HT; Chu L
Front Cell Dev Biol; 2023; 11():1136777. PubMed ID: 37009470
[TBL] [Abstract][Full Text] [Related]
11. Prognostic stratification of sepsis through DNA damage response based RiskScore system: insights from single-cell RNA-sequencing and transcriptomic profiling.
Lin Q; Zeng R; Yang J; Xu Z; Jin S; Wei G
Front Immunol; 2024; 15():1345321. PubMed ID: 38404591
[TBL] [Abstract][Full Text] [Related]
12. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a robust prognostic model based on immune features in sepsis.
Zheng Y; Liu B; Deng X; Chen Y; Huang Y; Zhang Y; Xu Y; Sang L; Liu X; Li Y
Front Immunol; 2022; 13():994295. PubMed ID: 36532037
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA-Seq and bulk RNA-Seq reveal reliable diagnostic and prognostic biomarkers for CRC.
Zhang X; Yang L; Deng Y; Huang Z; Huang H; Wu Y; He B; Hu F
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9805-9821. PubMed ID: 37247080
[TBL] [Abstract][Full Text] [Related]
16. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
Front Oncol; 2022; 12():938679. PubMed ID: 35982954
[TBL] [Abstract][Full Text] [Related]
17. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
18. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognosis-Related RNA-Binding Proteins to Reveal the Role of RNA-Binding Proteins in the Progression and Prognosis of Colon Cancer.
Ding Y; Fang L; Yang XP; Zou Q
Int J Gen Med; 2021; 14():6795-6805. PubMed ID: 34703285
[TBL] [Abstract][Full Text] [Related]
20. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]